P A van der Merwe
University of Oxford
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P A van der Merwe.
Nature Immunology | 2003
Jean-Baptiste Reiser; Claudine Darnault; Claude Grégoire; Thomas Mosser; G Mazza; A Kearnay; P A van der Merwe; Juan C. Fontecilla-Camps; Dominique Housset; Bernard Malissen
T cell receptor (TCR) binding degeneracy lies at the heart of several physiological and pathological phenomena, yet its structural basis is poorly understood. We determined the crystal structure of a complex involving the BM3.3 TCR and an octapeptide (VSV8) bound to the H-2Kb major histocompatibility complex molecule at a 2.7 Å resolution, and compared it with the BM3.3 TCR bound to the H-2Kb molecule loaded with a peptide that has no primary sequence identity with VSV8. Comparison of these structures showed that the BM3.3 TCR complementarity-determining region (CDR) 3α could undergo rearrangements to adapt to structurally different peptide residues. Therefore, CDR3 loop flexibility helps explain TCR binding cross-reactivity.
Current Biology | 2000
D Brodie; Alison V. Collins; Andrea Iaboni; J A Fennelly; Lisa M. Sparks; Xiao-Ning Xu; P A van der Merwe; Simon J. Davis
In mammals, the classical B7 molecules expressed on antigen-presenting cells, B7-1 (CD80) and B7-2 (CD86), bind the structurally related glycoproteins CD28 and CTLA-4 (CD152), generating costimulatory signals that regulate the activation state of T cells. A recently identified human CD28-like protein, ICOS, also induces costimulatory signals in T cells when crosslinked with antibodies, but it is unclear whether ICOS is part of a B7-mediated regulatory pathway of previously unsuspected complexity, or whether it functions independently and in parallel. Here, we report that, rather than binding B7-1 or B7-2, ICOS binds a new B7-related molecule of previously unknown function that we call LICOS (for ligand of ICOS). At 37 degrees C, LICOS binds only to ICOS but, at lower, non-physiological temperatures, it also binds weakly to CD28 and CTLA-4. Sequence comparisons suggest that LICOS is the homologue of a molecule expressed by avian macrophages and of a murine protein whose expression is induced in non-lymphoid organs by tumour necrosis factor alpha (TNFalpha). Our results define the components of a distinct and novel costimulatory pathway and raise the possibility that LICOS, rather than B7-1 or B7-2, is the contemporary homologue of a primordial vertebrate costimulatory ligand.
Journal of Biological Chemistry | 1999
Katsumi Maenaka; T. Juji; T. Nakayama; Jessica R. Wyer; George F. Gao; T. Maenaka; N. Zaccai; A. Kikuchi; T. Yabe; K. Tokunaga; K. Tadokoro; David I. Stuart; E. Y. Jones; P A van der Merwe
Human natural killer cells and a subset of T cells express a repertoire of killer cell immunoglobulin receptors (KIRs) that recognize major histocompatibility complex (MHC) class I molecules. KIRs and T cell receptors (TCRs) bind in a peptide-dependent manner to overlapping regions of peptide-MHC class I complexes. KIRs with two immunoglobulin domains (KIR2Ds) recognize distinct subsets of HLA-C alleles. Here we use surface plasmon resonance to study the binding of soluble forms of KIR2DL1 and KIR2DL3 to several peptide-HLA-Cw7 complexes. KIR2DL3 bound to the HLA-Cw7 allele presenting the peptide RYRPGTVAL with a 1:1 stoichiometry and an affinity (K d ∼7 μm at 25 °C) within the range of values measured for other cell-cell recognition molecules, including the TCR. Although KIR2DL1 is reported not to recognize the HLA-Cw7 allele in functional assays, it bound RYRPGTVAL/HLA-Cw7, albeit with a 10–20-fold lower affinity. TCR/peptide-MHC interactions are characterized by comparatively slow kinetics and unfavorable entropic changes (Willcox, B. E., Gao, G. F., Wyer, J. R., Ladbury, J. E., Bell, J. I., Jakobsen, B. K., and van der Merwe, P. A. (1999) Immunity 10, 357–365), suggesting that binding is accompanied by conformational adjustments. In contrast, we show that KIR2DL3 binds RYRPGTVAL/HLA-Cw7 with fast kinetics and a favorable binding entropy, consistent with rigid body association. These results indicate that KIR/peptide-MHC class I interactions have properties typical of other cell-cell recognition molecules, and they highlight the unusual nature of TCR/peptide-MHC recognition.
Journal of Biological Chemistry | 1998
Susan M. Lea; R. M. Powell; T. Mckee; David J. Evans; D.G Brown; David I. Stuart; P A van der Merwe
The biochemical properties of the molecular interactions mediating viral-cell recognition are poorly characterized. In this study, we use surface plasmon resonance to study the affinity and kinetics of the interaction of echovirus 11 with its cellular receptor decay-accelerating factor (CD55). As reported for interactions between cell-cell recognition molecules, the interaction has a low affinity (K D ∼3.0 μm) as a result of a very fast dissociation rate constant (k on∼105 m −1·s−1,k off ∼0.3 s−1). This contrasts with the interaction of soluble ICAM-1 (sICAM-1, CD54) with human rhinovirus 3 which has been reported to have a similar affinity but 102–103-fold slower kinetics (Casasnovas, J. M., and Springer, T. A. (1995) J. Biol. Chem.270, 13216–13224). The extracellular portion of decay-accelerating factor comprises four short consensus repeat domains (domains 1–4) and a mucin-like stalk. By comparison of the binding affinity for echovirus 11 of various fragments of decay-accelerating factor, we are able to conclude that short consensus repeat domain 3 contributes ∼80% of the binding energy.
Proceedings of the National Academy of Sciences of the United States of America | 1998
Simon J. Davis; Elizabeth A. Davies; Michael G. Tucknott; E.Y. Jones; P A van der Merwe
European Journal of Immunology | 1993
P A van der Merwe; D C McPherson; Marion H. Brown; A N Barclay; Jason G. Cyster; Alan F. Williams; Simon J. Davis
Journal of Biological Chemistry | 1995
Simon J. Davis; Elizabeth A. Davies; A N Barclay; S Daenke; Dale L. Bodian; E.Y. Jones; David I. Stuart; Terry D. Butters; Raymond A. Dwek; P A van der Merwe
Biophysical Journal | 2012
Jun Allard; Omer Dushek; Daniel Coombs; P A van der Merwe
Biochemical Society Transactions | 1993
Simon J. Davis; E.Y. Jones; Dale L. Bodian; A N Barclay; P A van der Merwe
Biochemical Society Transactions | 1995
Simon J. Davis; Elizabeth A. Davies; P A van der Merwe